{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:40:05Z","timestamp":1787647205385,"version":"build-2736575974"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.soc.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T18:29:58Z","timestamp":1667500198000},"page":"199-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Advances in Endocrine Surgery"],"prefix":"10.1016","volume":"32","author":[{"given":"Michael S.","family":"Lui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya S.","family":"Shirali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice L.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib1","first-page":"7","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archotol.136.11.1061","article-title":"Extent of surgery for papillary thyroid carcinoma: the debate continues: comment on \"surgery for papillary thyroid carcinoma","volume":"136","author":"Shaha","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib4","first-page":"55","article-title":"Differentiated and anaplastic thyroid carcinoma: Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"68","author":"Perrier","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.soc.2022.08.004_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1089\/thy.2017.0572","article-title":"Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions","volume":"28","author":"Tam","year":"2018","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/01.sla.0000250445.92336.2a","article-title":"Staging systems for papillary thyroid carcinoma: a review and comparison","volume":"245","author":"Lang","year":"2007","journal-title":"Ann Surg Mar"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/bjs5.50182","article-title":"Impact of the change from the seventh to eighth edition of the AJCC TNM classification of malignant tumours and comparison with the MACIS prognostic scoring system in non-medullary thyroid cancer","volume":"3","author":"Dwamena","year":"2019","journal-title":"BJS Open"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib8","first-page":"1088","article-title":"Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system","volume":"102","author":"Hay","year":"1987","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0039-6060(98)70034-0","article-title":"An expanded view of risk-group definition in differentiated thyroid carcinoma","volume":"104","author":"Cady","year":"1988","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib10","first-page":"1050","article-title":"Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989","volume":"114","author":"Hay","year":"1993","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9610(05)80326-5","article-title":"Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis","volume":"166","author":"Shah","year":"1993","journal-title":"Am J Surg"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib12","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0039-6060(98)70035-2","article-title":"Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?","volume":"124","author":"Hay","year":"1998","journal-title":"Surgery"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/SLA.0b013e31814697d9","article-title":"Extent of surgery affects survival for papillary thyroid cancer","volume":"246","author":"Bilimoria","year":"2007","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Tuttle. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer","volume":"19","author":"David","year":"2009","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/hed.21504","article-title":"Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer","volume":"33","author":"Barney","year":"2011","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/archoto.2010.181","article-title":"Surgery for papillary thyroid carcinoma: is lobectomy enough?","volume":"136","author":"Mendelsohn","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.surg.2011.08.016","article-title":"Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy","volume":"151","author":"Nixon","year":"2012","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","article-title":"Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients","volume":"260","author":"Adam","year":"2014","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2014-3039","article-title":"Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years","volume":"100","author":"Adam","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid : official J Am Thyroid Assoc"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MD.0b013e31826a9c71","article-title":"BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis","volume":"91","author":"Tufano","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.soc.2022.08.004_bib22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.2013.3190","article-title":"Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer","volume":"309","author":"Xing","year":"2013","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib23","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/thy.2015.0391","article-title":"BRAF(V600E) Is Correlated with Recurrence of Papillary Thyroid Microcarcinoma: A Systematic Review, Multi-Institutional Primary Data Analysis, and Meta-Analysis","volume":"26","author":"Chen","year":"2016","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.surg.2014.07.015","article-title":"Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer","volume":"157","author":"Niederer-W\u00fcst","year":"2015","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib25","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"25","key":"10.1016\/j.soc.2022.08.004_bib26","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib27","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1203208","article-title":"Preoperative diagnosis of benign thyroid nodules with indeterminate cytology","volume":"367","author":"Alexander","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1089\/thy.2015.0305","article-title":"Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance\/Follicular Lesion of Undetermined Significance Cytology","volume":"25","author":"Nikiforov","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamaoncol.2020.5935","article-title":"Effectiveness of Molecular Testing Techniques for Diagnosis of Indeterminate Thyroid Nodules: A Randomized Clinical Trial","volume":"7","author":"Livhits","year":"2021","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072503321669875","article-title":"An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid","volume":"13","author":"Ito","year":"2003","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","article-title":"An observational trial for papillary thyroid microcarcinoma in Japanese patients","volume":"34","author":"Ito","year":"2010","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/thy.2015.0178","article-title":"A\u00a0Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib33","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00268-015-3300-5","article-title":"Quality of Life in Thyroid Cancer is Similar to That of Other Cancers with Worse Survival","volume":"40","author":"Applewhite","year":"2016","journal-title":"World J Surg"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.surg.2019.11.014","article-title":"Financial burden and quality of life among thyroid cancer survivors","volume":"167","author":"Mongelli","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2022.08.004_bib35","doi-asserted-by":"crossref","DOI":"10.1089\/thy.2021.0485","article-title":"A\u00a0Quantitative Analysis Examining Patients' Choice of Active Surveillance or Surgery for Managing Low-Risk Papillary Thyroid Cancer","author":"Sawka","year":"2022","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib36","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/1097-0142(197011)26:5<1061::AID-CNCR2820260514>3.0.CO;2-Z","article-title":"Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision","volume":"26","author":"Noguchi","year":"1970","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib37","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0039-6060(03)00424-0","article-title":"Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer","volume":"134","author":"Kouvaraki","year":"2003","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.surg.2011.09.003","article-title":"A\u00a0multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer","volume":"150","author":"Popadich","year":"2011","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.soc.2022.08.004_bib39","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1245\/s10434-018-6528-0","article-title":"Prophylactic Central Compartment Neck Dissection in Papillary Thyroid Cancer and Effect on Locoregional Recurrence","volume":"25","author":"Hughes","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib40","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1245\/s10434-013-3125-0","article-title":"A\u00a0meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer","volume":"20","author":"Wang","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.soc.2022.08.004_bib41","series-title":"Thyroid-differentiated and anaplastic carcinoma (Chapter 73)","author":"Tuttle","year":"2017"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib42","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.surg.2014.03.027","article-title":"The impact of nodal status on outcome in older patients with papillary thyroid cancer","volume":"156","author":"Nixon","year":"2014","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.surg.2010.03.021","article-title":"Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit","volume":"148","author":"Shen","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2022.08.004_bib44","doi-asserted-by":"crossref","first-page":"571480","DOI":"10.1155\/2015\/571480","article-title":"The Benefits and Risks of Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma: Prospective Cohort Study","volume":"2015","author":"Lee","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib45","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1210\/jc.2014-3825","article-title":"Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study","volume":"100","author":"Viola","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00405-019-05702-3","article-title":"Randomized trial of prophylactic ipsilateral central lymph node dissection in patients with clinically node negative papillary thyroid microcarcinoma","volume":"277","author":"Kim","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib47","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/SLA.0000000000004345","article-title":"A\u00a0Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer","volume":"272","author":"Sippel","year":"2020","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.surg.2021.03.071","article-title":"A\u00a0prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma","volume":"171","author":"Ahn","year":"2022","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2022.08.004_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000005388","article-title":"Prophylactic Central Neck Lymph Node Dissection in Low-Risk Thyroid Carcinoma Patients Does not Decrease the Incidence of Locoregional Recurrence: A Meta-Analysis of Randomized Trials","author":"Sanabria","year":"2022","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib50","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1089\/thy.2018.0554","article-title":"Lobectomy Is Feasible for 1-4\u00a0cm Papillary Thyroid Carcinomas: A 10-Year Propensity Score Matched-Pair Analysis on Recurrence","volume":"29","author":"Song","year":"2019","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.soc.2022.08.004_bib51","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib52","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archsurg.141.8.777","article-title":"Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model","volume":"141","author":"Kebebew","year":"2006","journal-title":"Arch Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib53","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1210\/clinem\/dgaa779","article-title":"Use of Preoperative Imaging in Primary Hyperparathyroidism","volume":"106","author":"Broome","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1245\/s10434-011-1870-5","article-title":"A\u00a0meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism","volume":"19","author":"Cheung","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3174\/ajnr.A5901","article-title":"Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT","volume":"40","author":"Vu","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib56","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.amjsurg.2021.09.015","article-title":"Four-dimensional computed tomography (4D-CT) for preoperative parathyroid localization: A good study but are we using it?","volume":"223","author":"Kuo","year":"2022","journal-title":"Am J Surg"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib57","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jamcollsurg.2011.12.022","article-title":"Outcomes and economic analysis of routine preoperative 4-dimensional CT for surgical intervention in de novo primary hyperparathyroidism: does clinical benefit justify the cost?","volume":"214","author":"Abbott","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"issue":"13","key":"10.1016\/j.soc.2022.08.004_bib58","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1245\/s10434-012-2512-2","article-title":"Preoperative localization strategies for primary hyperparathyroidism: an economic analysis","volume":"19","author":"Lubitz","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib59","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.surg.2011.09.016","article-title":"Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism","volume":"150","author":"Wang","year":"2011","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib60","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.surg.2021.05.056","article-title":"Superior sensitivity of (18)F-fluorocholine: PET localization in primary hyperparathyroidism","volume":"171","author":"Graves","year":"2022","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.soc.2022.08.004_bib61","article-title":"(18)F-Fluorocholine PET and 4D-CT in Patients with Persistent and Recurrent Primary Hyperparathyroidism","volume":"11","author":"Latge","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib62","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/archsurg.141.5.483","article-title":"Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients","volume":"141","author":"Chiu","year":"2006","journal-title":"Arch Surg May"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib63","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.surg.2021.05.030","article-title":"Focused parathyroidectomy without intraoperative parathyroid hormone measurement in primary hyperparathyroidism: Still a valid approach?","volume":"170","author":"Di Marco","year":"2021","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib64","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.surg.2013.06.046","article-title":"A\u00a0novel optical approach to intraoperative detection of parathyroid glands","volume":"154","author":"McWade","year":"2013","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.surg.2015.06.047","article-title":"Establishing the clinical utility of autofluorescence spectroscopy for parathyroid detection","volume":"159","author":"McWade","year":"2016","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.surg.2021.01.033","article-title":"Development of an algorithm for intraoperative autofluorescence assessment of parathyroid glands in primary hyperparathyroidism using artificial intelligence","volume":"170","author":"Akbulut","year":"2021","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib67","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1245\/s10434-019-07161-w","article-title":"Intraoperative Parathyroid Autofluorescence Detection in Patients with Primary Hyperparathyroidism","volume":"26","author":"Squires","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2022.08.004_bib68","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1089\/thy.2021.0056","article-title":"Near-Infrared Autofluorescence Imaging May Reduce Temporary Hypoparathyroidism in Patients Undergoing Total Thyroidectomy and Central Neck Dissection","volume":"31","author":"Kim","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.soc.2022.08.004_bib69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000491039","article-title":"Parathyroid Carcinoma","volume":"51","author":"Cetani","year":"2019","journal-title":"Front Horm Res"},{"key":"10.1016\/j.soc.2022.08.004_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2017.01.060","article-title":"Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma","author":"Silva-Figueroa","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib71","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1245\/s10434-019-07451-3","article-title":"Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center","volume":"26","author":"Asare","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib72","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.surg.2014.08.005","article-title":"Is central lymph node dissection necessary for parathyroid carcinoma?","volume":"156","author":"Hsu","year":"2014","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib73","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.beem.2018.11.002","article-title":"Parathyroid carcinoma","volume":"32","author":"Salcuni","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib74","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00432-019-02945-9","article-title":"Genetic profiling as a clinical tool in advanced parathyroid carcinoma","volume":"145","author":"Kutahyalioglu","year":"2019","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib75","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1634\/theoncologist.2018-0334","article-title":"Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib76","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.surg.2018.06.013","article-title":"Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages","volume":"164","author":"Silva-Figueroa","year":"2018","journal-title":"Surg Nov"},{"issue":"9","key":"10.1016\/j.soc.2022.08.004_bib77","first-page":"13","article-title":"Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab","author":"Park","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.soc.2022.08.004_bib78","doi-asserted-by":"crossref","first-page":"643328","DOI":"10.3389\/fendo.2021.643328","article-title":"Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management","volume":"12","author":"Lenschow","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib79","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/10926420152761941","article-title":"Laparoscopic adrenalectomy: the optimal surgical approach","volume":"11","author":"Kebebew","year":"2001","journal-title":"J\u00a0Laparoendosc Adv Surg Tech A"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib80","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jamcollsurg.2008.01.018","article-title":"Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program","volume":"206","author":"Lee","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jss.2013.04.014","article-title":"Comparison of laparoscopic versus open adrenalectomy: results from American College of Surgeons-National Surgery Quality Improvement Project","volume":"184","author":"Elfenbein","year":"2013","journal-title":"J\u00a0Surg Res"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib82","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s00268-014-2454-x","article-title":"Adrenal metastectomy is safe in selected patients","volume":"38","author":"Romero Arenas","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.soc.2022.08.004_bib83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jss.2018.07.003","article-title":"The Posterior Adiposity Index: A Quantitative Selection Tool for Adrenalectomy Approach","volume":"233","author":"Lindeman","year":"2019","journal-title":"J\u00a0Surg Res"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib84","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/SLA.0000000000002603","article-title":"Lateral Transperitoneal Adrenalectomy Versus Posterior Retroperitoneoscopic Adrenalectomy for Benign Adrenal Gland Disease: Randomized Controlled Trial at a Single Tertiary Medical Center","volume":"269","author":"Chai","year":"2019","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib85","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/SLA.0000000000000982","article-title":"Randomized clinical trial of posterior retroperitoneoscopic adrenalectomy versus lateral transperitoneal laparoscopic adrenalectomy with a 5-year follow-up","volume":"260","author":"Barczy\u0144ski","year":"2014","journal-title":"Ann Surg Nov"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib86","first-page":"160","article-title":"Laparoscopic adrenalectomy: lateral transperitoneal versus posterior retroperitoneal approach - prospective randomized trial","volume":"14","author":"Koz\u0142owski","year":"2019","journal-title":"Wideochir Inne Tech Maloinwazyjne"},{"issue":"10 Pt A","key":"10.1016\/j.soc.2022.08.004_bib87","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.ejso.2020.04.001","article-title":"Surgical outcomes of a randomized controlled trial compared robotic versus laparoscopic adrenalectomy for pheochromocytoma","volume":"46","author":"Ma","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib88","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1245\/s10434-015-4803-x","article-title":"Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes","volume":"23","author":"Margonis","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib89","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1245\/s10434-020-08824-9","article-title":"Implications of Conversion during Attempted Minimally Invasive Adrenalectomy for Adrenocortical Carcinoma","volume":"28","author":"Delozier","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib90","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jamcollsurg.2016.05.015","article-title":"Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma","volume":"223","author":"Huynh","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1245\/s10434-009-0716-x","article-title":"Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane","volume":"17","author":"Grubbs","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib92","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib93","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/SLA.0000000000003876","article-title":"Adrenalectomy for Secondary Malignancy: Patients, Outcomes, and Indications","volume":"274","author":"Wachtel","year":"2021","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.amjsurg.2007.12.018","article-title":"Melanoma adrenal metastasis: natural history and surgical management","volume":"195","author":"Mittendorf","year":"2008","journal-title":"Am J Surg Mar"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib95","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s00268-012-1506-3","article-title":"Adrenalectomy improves outcomes of selected patients with metastatic carcinoma","volume":"36","author":"Vazquez","year":"2012","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib96","first-page":"6","article-title":"Outcome and prognosis after adrenal metastasectomy: nationwide study","author":"Vlk","year":"2022","journal-title":"BJS Open"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib97","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/SLA.0000000000002749","article-title":"Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease","volume":"270","author":"Russo","year":"2019","journal-title":"Ann Surg Aug"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib98","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib99","first-page":"318","article-title":"Resistant hypertension and aldosterone: an update","volume":"28","author":"Clark","year":"2012","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/j.soc.2022.08.004_bib100","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib101","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"39","key":"10.1016\/j.soc.2022.08.004_bib102","doi-asserted-by":"crossref","first-page":"e4986","DOI":"10.1097\/MD.0000000000004986","article-title":"Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib103","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cen.13582","article-title":"Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism","volume":"88","author":"Umakoshi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib104","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1530\/EC-17-0232","article-title":"Preoperative selective vs non-selective \u03b1-blockade in PPGL patients undergoing adrenalectomy","volume":"6","author":"Liu","year":"2017","journal-title":"Endocr Connect"},{"issue":"7","key":"10.1016\/j.soc.2022.08.004_bib105","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/clinem\/dgz188","article-title":"Efficacy of \u03b1-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial","volume":"105","author":"Buitenwerf","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib106","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1213\/ANE.0000000000005070","article-title":"Nonselective Compared With Selective \u03b1-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching","volume":"132","author":"Kong","year":"2021","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib107","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.surg.2012.08.023","article-title":"Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas","volume":"152","author":"Siddiqi","year":"2012","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib108","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.surg.2014.08.022","article-title":"Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma","volume":"156","author":"Brunaud","year":"2014","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib109","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/bja\/aew392","article-title":"Perioperative \u03b1-receptor blockade in phaeochromocytoma surgery: an observational case series","volume":"118","author":"Groeben","year":"2017","journal-title":"Br J Anaesth Feb"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/SLA.0000000000002195","article-title":"Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma","volume":"268","author":"Roman-Gonzalez","year":"2018","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib111","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MPA.0000000000001792","article-title":"The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and\/or Unresectable Pheochromocytoma and Paraganglioma","volume":"50","author":"Fishbein","year":"2021","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib112","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12542","article-title":"Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis","volume":"81","author":"Niemeijer","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib113","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2967\/jnumed.118.217463","article-title":"Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma","volume":"60","author":"Pryma","year":"2019","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib114","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.esmoop.2021.100171","article-title":"Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials","volume":"6","author":"Severi","year":"2021","journal-title":"ESMO Open"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib115","first-page":"12","article-title":"Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas","author":"Jimenez","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib116","doi-asserted-by":"crossref","first-page":"L51","DOI":"10.1530\/ERC-17-0086","article-title":"SDHB mutation carriers with malignant pheochromocytoma respond better to CVD","volume":"24","author":"Fishbein","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib117","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.28913","article-title":"SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma","volume":"135","author":"Hadoux","year":"2014","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.soc.2022.08.004_bib118","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1210\/jc.2012-2356","article-title":"Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas","volume":"97","author":"Ayala-Ramirez","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib119","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib120","doi-asserted-by":"crossref","first-page":"e198898","DOI":"10.1001\/jamanetworkopen.2019.8898","article-title":"Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy","volume":"2","author":"Neumann","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib121","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jamcollsurg.2012.10.012","article-title":"Long-term outcomes of surgical treatment for hereditary pheochromocytoma","volume":"216","author":"Grubbs","year":"2013","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.soc.2022.08.004_bib122","first-page":"1440","article-title":"Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib123","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib124","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1210\/clinem\/dgaa120","article-title":"The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers","volume":"105","author":"Athimulam","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.soc.2022.08.004_bib125","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.surg.2012.08.054","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.soc.2022.08.004_bib126","first-page":"406","article-title":"Adrenal incidentalomas and subclinical Cushing syndrome: indications to surgery and results in a series of 26 laparoscopic adrenalectomies","volume":"86","author":"Pisano","year":"2015","journal-title":"Ann Ital Chir"},{"issue":"3","key":"10.1016\/j.soc.2022.08.004_bib127","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2022.08.004_bib128","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00268-007-9408-5","article-title":"The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH)","volume":"32","author":"Iacobone","year":"2008","journal-title":"World J Surg"},{"issue":"12","key":"10.1016\/j.soc.2022.08.004_bib129","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1210\/jc.2015-2662","article-title":"Unilateral Adrenalectomy as a First-Line Treatment of Cushing's Syndrome in Patients With Primary Bilateral Macronodular Adrenal Hyperplasia","volume":"100","author":"Debillon","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.soc.2022.08.004_bib130","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00268-013-2059-9","article-title":"The role of unilateral adrenalectomy in corticotropin-independent bilateral adrenocortical hyperplasias","volume":"37","author":"Xu","year":"2013","journal-title":"World J Surg"},{"issue":"7","key":"10.1016\/j.soc.2022.08.004_bib131","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1210\/jc.2018-02204","article-title":"Long-Term Outcome of Primary Bilateral Macronodular Adrenocortical Hyperplasia After Unilateral Adrenalectomy","volume":"104","author":"Osswald","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.soc.2022.08.004_bib132","first-page":"19311","article-title":"Classification and surgical treatment for 180 cases of adrenocortical hyperplastic disease","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.soc.2022.08.004_bib133","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.surg.2020.05.046","article-title":"Early assessment of postoperative adrenal function is necessary after adrenalectomy for mild autonomous cortisol secretion","volume":"169","author":"Foster","year":"2021","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.soc.2022.08.004_bib134","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/jc.2014-1401","article-title":"Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.soc.2022.08.004_bib135","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1210\/clinem\/dgab698","article-title":"Selective Glucocorticoid Replacement Following Unilateral Adrenalectomy for Hypercortisolism and Primary Aldosteronism","volume":"107","author":"DeLozier","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320722000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:05:19Z","timestamp":1760961919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320722000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1055320722000667"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2022.08.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Endocrine Surgery","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}